Foundation's Open Source Contributions from Financial Institutions Continues to Increase in 2020

NEW YORK, NY / ACCESSWIRE / June 17, 2020 / As the financial services industry continues to embrace collaborative open source projects to keep pace with rapid technological change, FINOS (the Fintech Open Source Foundation), a nonprofit whose mission is to foster adoption of open source, open standards, and collaborative software development practices in financial services, today announces three new codebase contributions. The new projects represent diverse solutions to solving common software problems, large and small.

"Working closely with Platinum members Citi, Deutsche Bank and ChartIQ, a Silver fintech member, we've deepened our reservoir of open source projects that address specific needs in financial services," said Gab Columbro, executive director, FINOS. "From desktop applications to large-scale enterprise information management, these new additions to our community demonstrate how open source is driving positive change in the industry, as more financial institutions see business value not only in consuming but, most importantly, contributing to open source."

Citi Synthetic DataHub Helps Institutions Test Information and Keep it Confidential

Gaining the ability to use confidential data sets with external cloud services can be a lengthy process. A lack of useful test data often slows the development of new systems. To address this, Citi created DataHub to generate synthetic data to address the need for anonymization when working with cloud providers. DataHub is a set of Python libraries dedicated to the production of synthetic data to be used in tests, machine learning training, statistical analysis, and other related use cases.

DataHub was developed as part of a Citi Engineering Excellence program to deliver innovative software. Citi's highest-level program, E4, allows developers to pitch ideas, gain sponsorship and deliver as an individual contributor over a six-month period. After completion E4 graduates continue to take their project forward while working on challenging firm-wide initiatives.

Citi's DataHub engine enables developers to quickly create synthetic data sets to meet the growing needs of regulators and businesses looking to innovate without compromising sensitive information.

"Citi is extremely excited to make this important contribution to the growing FINOS community," said Ali Villagra, global head of Citi Velocity. "We believe it will accelerate innovation in the rapidly evolving data space and help drive adoption of open source in the financial services community."

Waltz Helps Companies Get a Better Handle on Internal Technology Landscape

Primarily developed by Deutsche Bank and Khartec Ltd, Waltz helps large financial institutions understand their technology architecture in a consistent, well-documented and easily digestible format. Deutsche Bank recently contributed the project to FINOS. Waltz shows where applications reside, what they do and how they are connected. It has been used to assist with key performance metrics, data lineage, regulatory responses and application rationalization and migration programs.

"The work we've done to develop Waltz has been critical in tackling a range of challenges, many of which are common to our peers," said Russell Green, Deutsche Bank's chief architect. "For example, it is central to the way we manage our applications and technology risk, while also providing a basis for application forecasting as part of our IT strategy. Ultimately it helps us to develop a clear picture of our technology usage now and in the future. Contributing Waltz to the pantheon of FINOS projects means we can better share the benefits across the industry and drive common approaches to regulatory demands, which is an essential part of open source innovation."

ChartIQ's SEA Project Seeks to Provide Greater Security for Desktop Application Solutions

The popularity of building desktop applications leveraging the power of Electron–a container for creating desktop applications with web technologies, and also a project housed within the overall Linux Foundation family of projects–is growing. When bringing web technology to the desktop, risks should be mitigated. The Secure Electron Adapter (SEA) looks to provide a secure alternative to working directly with the Electron API. SEA acts as a firewall, intermediating API calls within a permission structure that obviates the risk of running third party content on the desktop. Electron is widely used by solutions providers that build individual applications or create application interoperability.

"Solutions providers can now leverage the power of Electron with an added layer of security," said Dan Schleifer, CEO, and co-founder of ChartIQ. "With this open-source project, financial institutions can fast-track securing Electron, and use SEA as a building block to provide the best possible smart desktop user experience."

Open Source Contributions from Financial Institutions Increasing

These additions bring the total announced contributions made into FINOS since early 2019 to 14. Over 35 percent of these contributions were made by financial institutions that also are FINOS platinum members. This represents a significant increase from previous years, not only demonstrating the strong pipeline of activity on the heels of FINOS' recent acquisition by the Linux Foundation in April, but underlining how open source is now a key pillar for modern firms. Also, it is evidence that FINOS has enabled the industry to enact their open source strategy efficiently and in a compliant manner.

Waltz and Synthetic Data are just the latest examples of large-scale contributions being made by FINOS investment banking Platinum members. In early-2019, JP Morgan made its contribution of Perspective and in late-2019, Goldman Sachs announced its intention to contribute Alloy, that bank's internal logical modeling language and toolset into the foundation. FINOS has grown to 33 members since its founding in 2018 with major financial institutions, innovative fintechs and well-respected consultancies.

# # #

About FINOS

The Fintech Open Source Foundation (FINOS) is an independent nonprofit organization focused on promoting open innovation during a period of unprecedented technological transformation within financial services. FINOS believes that organizations that embrace open source software development and common standards will be best positioned to capture the growth opportunities presented by this transformation. The Foundation offers an Open Developer Platform (ODP), a compliant Open Source Readiness Program and The Open Source Strategy Forum (OSSF), the leading global event for financial executives and technologists dedicated to open innovation. Foundation OSS Projects are Apache 2.0 licensed and available on GitHub. For more information, visit www.finos.org or our Github organization at github.com/finos.

Media Contact

Stephen Sumner
Caliber Corporate Advisers
stephen@calibercorporateadvisers.com
p. 917.985.6630 ext.15

SOURCE: FINOS

ReleaseID: 594134

NEWPORT BEACH, CA / ACCESSWIRE / June 17, 2020 / Commentator and entrepreneur, Charles Laverty has warned that over 20 million small businesses are beyond saving and has called for a "Small Business Marshall Plan" to stave off the disaster caused by the ongoing Coronavirus lockdowns.

Laverty notes that the various bailout payments and programs did not change the fundamental problem facing the more than 30 million small US businesses. The loss in revenues has been dramatic, often 75% or more, he says but business costs have mostly remained unchanged. This, Laverty notes is why, even with trillions in Federal and State funds spent to "save jobs," the US has already registered 44 million new unemployment claims in just a matter of weeks.

By adapting to the lockdowns and mandatory closures, businesses have mostly continued to operate on revenues which have typically been reduced by 75 to 80%. Meanwhile those business owners have seen losses soar as everything from taxes and labor to rent, utilities, shipping and supplier costs have remained high. The result has been that exhausted business owners have also exhausted their options and resources. Hundreds of thousands of these business owners are not even in a position to reopen when allowed.

Worse, says Charles Laverty, the way we are reopening dangles the false promise of a V-shaped recovery that simply is not coming. Most business production is still handicapped by restrictions of some kind. So even those that have demand for their products and services simply cannot get to full production.

Businesses are simply not profitable with social distancing and other restrictions. There is no way to alter that fact, he argues. Most small businesses are not massively profitable in the best of times, he points out. If you make them operate at 50% or 75% capacity, then you are guaranteeing that most will operate at losses. You can only operate at a loss for so long before the damage becomes permanent.

Laverty Launched Nuzuna Fitness in 2018 and notes that the fast-growing operator of technology enabled fitness programs, physical therapy personal training, wellness products has watched smaller, fitness businesses teeter on the edge of failure. Allowed to limp forward on their own, many businesses will not survive this start-and-stop approach of partial reopening. Many millions of firms will never recover the cash, assets and inventory needed to survive the inevitable business challenges they will face over the next year. As a result, business failures will spike and stay that way for at least twelve months.

When 20 million businesses fail this will lead to a systemic, long term recession that will take years, if not decades to recover from. You may coldly argue that market forces ensure that new businesses will rise to take the place of the failures. But with an entire generation of entrepreneurs mentally and financially exhausted who will launch these businesses?

Widespread business failures will lead to massive oversupply of used commercial space, equipment and supplies which must be liquidated. Suppliers in every industry will face years of exceptionally low demand for new products and supplies. All of this will create higher systemic unemployment which will depress consumer demand and further hurt consumer savings.

This doesn't lead to a recession like we have come to know it. A recession is a relatively small, but nevertheless painful reduction in GDP lasting months or a year or so. Typically, it is caused by a contraction of consumer and business spending. Instead, the self-inflicted wounds of the Coronavirus response leads to a systemic, across-the-board shift of supply and demand that takes the US economy back perhaps decades economically.

Charles Laverty says the only way to avoid this is to combine a nation-wide, full, unrestricted reopening with a recovery plan modeled on the Marshall Plan that the United States devised after World War II. "I am fiscally conservative," says Charles Laverty "but this situation was caused by non-market forces from political and health leaders. We cannot expect the market cannot fix it on its own without unbearable pain."

Writing on his blog, Laverty says that a true and full reopening will help demand recover and get people working and spending. Only that combined with massive government spending can eliminate the gap between revenues and costs while refilling the inventories and bank accounts of tens of millions of business owners.

For More Information

Charles Laverty

Nuzuna Fitness

949-432-4824

info@nuzunafit.com

1451 Quail Street Ste 104

Newport Beach, CA 92660

SOURCE: Nuzuna Fitness

ReleaseID: 594193

Report Recommends Consideration Should Be Given to BolaWrap® Being Provided to All Front-Line Officers

TEMPE, AZ / ACCESSWIRE / June 17, 2020 / Wrap Technologies, Inc. (the "Company" or "Wrap") (NASDAQ:WRTC), an innovator of modern policing solutions, announced it has received a report about BolaWrap® authored by the following United Kingdom (UK) use of force experts:

Mr Eric Baskind LLB (Hons) LLM FHEA MCIArb
Consultant in the Legal and Practical Aspects of the Use of Force
Consultant and Expert Witness in Violence Reduction and the Safer Use of Force; Senior Lecturer in Law, Liverpool John Moores University. Chair, Centre for Physical Interventions, British Self Defence Governing Body

Dr Anthony Bleetman PhD FRCSEd FRCEM DipIMC RCSEd
Consultant in Emergency Medicine
Honorary Clinical Associate Professor, University of Warwick Medical School

Mr Peter Turner BSc Violence Reduction in Professional Practice
Violence Reduction Specialist / PMVA Operational Lead High Secure Services
West London NHS Trust, Broadmoor Hospital

Management Commentary

"We believe the 38-page report titled "Report on the Efficacy and Safety of BolaWrap®" provides valuable information to support law enforcement agencies around the world to consider BolaWrap for all front-line officers," said David Norris, CEO of Wrap Technologies.

"I worked with Dr. Bleetman extensively in the early 2000s and he was instrumental in helping introduce TASERs into the UK market," said Tom Smith, President of Wrap Technologies. "Dr. Bleetman is extremely well respected and has worked in this space for many years – – I was very excited to see him involved with this project. As expected, during the live demonstration of the BolaWrap, Dr. Bleetman was the first to volunteer to be wrapped and experience remote restraint."

The UK Report lists the potential risk of injury to the subject of different interventions and use-of-force options in the following table:

Report Recommendations:

BolaWrap® is a new device with limited operational experience to date. Accordingly, we recommend scenario reconstruction and operational trials so that the efficacy of the device can be determined to minimise any operational risks to police officers, subjects and third parties in the immediate environment.
We recommend that the potential role for BolaWrap® in UK policing is tested in reconstructions and in scenarios in which a CED was deployed so that a reasonable comparison can be made.
We recommend that Guidelines and Protocols should be drawn up for the use of BolaWrap®
We recommend that BolaWrap® use should be included within the national use-of-force reporting process so that its efficacy and association with injury can be identified and monitored.
Subject to satisfactory testing, and given the relatively low risk of injury to officers, subjects and third parties in the immediate environment, we recommend that consideration should be given to BolaWrap® being provided to all front-line officers.

The UK Report summary is available on the company website here, and law enforcement agencies my request the full report by contacting Wrap Technologies, Inc.

Declaration of Interest Statement

The Authors have been paid by Emergency Protection Ltd, the exclusive UK distributor for Wrap Technologies, for their time in researching and producing this report. The Authors have not entered into any arrangement with Emergency Protection Ltd or any other party where the amount or payment of their fee is in any way dependent on the outcome of this report. We know of no conflict of interest of any kind, other than which we have disclosed in this section. Dr Bleetman is a serving member of SACMILL, a UK Ministry of Defence advisory body. (Scientific Advisory Committee on the Medical Implications of Less-Lethal Weapons). He has advised the current chair of SACMILL that he is undertaking this medical review for BolaWrap who has cleared this with the Surgeon General. In the event that BolaWrap is brought before SACMILL for evaluation, Dr Bleetman will not be part of that process.

About Wrap Technologies (NASDAQ:WRTC)

Wrap Technologies is an innovator of modern policing solutions. The Company's BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company's Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.wraptechnologies.com. Examples of recent media coverage are available as links under the "Media" tab of the website.

Trademark Information: BolaWrap and Wrap are trademarks of Wrap Technologies, Inc. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements – Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, total addressable market and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ability to successful implement training programs for the use of its products; the Company's ability to manufacture and produce product for its customers; the Company's ability to develop sales for its new product solution; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company's product solution; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for counties outside of the US; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company's ability to maintain and enhance its brand, as well as other risk factors included in the Company's most recent annual report on Form 10-K, quarterly report on Form 10-Q and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

WRAP TECHNOLOGIES CONTACT:
Paul M. Manley
VP – Investor Relations
612-834-1804
pmanley@wraptechnologies.com

SOURCE: Wrap Technologies, Inc.

ReleaseID: 594167

LOS ANGELES and DESERT HOT SPRINGS, CA / ACCESSWIRE / June 17, 2020 / Grapefruit USA, Inc., (OTC PINK:GPFT) ("Grapefruit" or the "Company"), a California based cannabis company, is announcing the presale of Grapefruit's ‘second harvest' of its AAA premium-quality indoor cannabis flowers based on the quality and success of its ‘First Harvest earlier this month. Grapefruit's utilizes a state-of-the-art atmosphere controlled, indoor Canopy grow system and an expert cultivation team to produce Grapefruit's premium grade Cannabis flowers.

The cannabis flowers' strains in Grapefruit's second harvest include ‘Wedding Cake', ‘Gelato 33' and 'Fire OG,' all highly sought-after strains in the Southern California market. In the next quarter Grapefruit's 'Runtz', a highly potent and desirable strain in So Cal., will be ready for harvest. In addition, Grapefruit's cultivation contract grants Grapefruit the right to purchase the "sugar trim" resulting from the hand trimming process of the harvested flowers which have many uses such a cannabis extracts and pre-rolls.

With respect to Grapefruit's presale of its 'second harvest' of its AAA indoor cannabis flowers, Bradley J. Yourist, Grapefruit CEO, stated, "Grapefruit was able to presell our second harvest based on the high-quality and rich terpene profiles of our first harvested flowers earlier this month. We have witnessed first-hand how the California market is seeing price acceleration resulting from increased demand for high-grade indoor grown cannabis flowers. Grapefruit's steady supply of high-quality indoor cannabis flowers for both white-label celebrity brands, Grapefruit's proprietary product lines and wholesale distribution customers is very advantageous to our Company.

Grapefruit will continue to work hand in glove with our Cultivator to continue our successful collaboration going into the future."

To learn more about Grapefruit, please visit our website at:

https://grapefruitblvd.com/investor-relations/

Follow us on Facebook, Instagram, LinkedIn and Twitter

Facebook | Instagram | LinkedIn | Twitter

About GRAPEFRUIT

Grapefruit's corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit's extraction laboratory and distribution facilities are located in the industry recognized Coachillin' Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 14 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit's vision remains to become a seed to sale, fully vertically integrated ethical and compliant cannabis product Company. To obtain further information on Grapefruit and its operations, please visit its website at https://grapefruitblvd.com/. To learn more about Grapefruit's Sugar Stoned branded line of cannabis and CBD infused edibles, please visit us at https://sugarstoned.com/.

Safe Harbor Statement

Grapefruit cautions you that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words "anticipate," "believe," "estimate," "may" "intend," "expect" and similar expressions. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the company and are subject to a number of risks and uncertainties inherent in Grapefruit's business, including, without limitation: the company may not ever obtain additional funds necessary to support its business development and growth plans; and the company may not ever achieve the market success to reach or sustain a profitable business. In addition, there are risks and uncertainties related to economic recession or terrorist actions, competition from much larger cannabis companies, unexpected costs and delays, potential product liability claims, and many other factors. More detailed information about Grapefruit and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K, its Quarterly Report on Form 10-Q/A for the period ended March 31, 2020 and its Registration Statement on Form S-1/A. Such documents may be read free of charge on the SEC's website at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Grapefruit undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Investor Relations Contact:
Bradley Yourist
brad@grapefruitblvd.com
18776 Blue Dream Crossing, Unit LL1 53-07
Desert Hot Springs, California 92240
(760) 205-1382
https://grapefruitblvd.com/

SOURCE: Grapefruit USA

ReleaseID: 594164

The Retired Green Beret And Host Of Four Network Television Survival Programs Will Begin Production On A Weekly Contest For Company's Synchronized Mobile And Digital Gaming Platform

LOS ANGELES, CA / ACCESSWIRE / June 17, 2020 / Clickstream Corp (OTC PINK:CLIS) announced today that Mykel Hawke has joined the company to host a weekly "Survival" focused trivia show on the soon to be launched WinQuik mobile technology gaming platform.

Mykel Hawke's service to America spans a twenty-five-year career in the US Army Special Forces; also know as the Green Berets. After his service Hawke authored nine books, twelve articles for magazines and hosted six network television series including: Lost Survivors (Travel Channel), Elite Tactical Unit (Outdoor Channel), Man, Woman Wild (Discovery Channel), One Man Army (Discovery Chanel), Out Of The Wild – Alaska (Discovery Channel) and Castaways Exposed (BBC). He also appeared in several UK based TV programs and additional US credits include Top Chef, Tactical To Practical, Good Morning America, Bizarre Foods, The Negotiator and the CBA pilot The Operatives.

Mykel's survival and combat training and experience has led to the development of fifty survival-based products.

Amber Theoharis, Vice President of Original Programming, for Clickstream's WinQuik platform states, "Mykel's service to our nation coupled with his real world and television experience will enable us to create a unique trivia gaming program that will not only be entertaining, it will be educational."

Clickstream is actively identifying TV and entertainment personalities for programs as the company scales to deliver programming for the world's first synchronized mobile and digital network. The platform will feature gaming shows and content designed for users seeking the thrill of live competition to win cash and prizes.

ABOUT CLICKSTREAM CORPORATION

ClickStream's business operations are focused on the development of a free to play Mobile App that caters to the casual user that will spend a few seconds to interact with a gaming platform in order to win real money. Initially, ClickStream's games will be quick to play trivia games that allow users to get involved in around 20 seconds and then receive results from push notifications. Game types are set up dynamically with non-live game shows daily and live game shows with Hosts 2 to 4 times per month. ClickStream intends to initially monetize the App with corporate sponsors and advertisers. For more information please visit Clickstream's websites at www.clickstream.technology or www.WinQuik.com as well as on Twitter at @ClickstreamC and @WinQuikApp.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

FOR MORE INFORMATION, PLEASE CONTACT:

Adam Handelsman
SpecOps Communications
adam@specopscomm.com
O: (512) 363-0594
C: (646) 413-9401

SOURCE: ClickStream Corporation

ReleaseID: 594092

Focused on Three-Prong Strategic Growth Plan for 2020

LOS ANGELES, CA / ACCESSWIRE / June 17, 2020 / Pacific Ventures Group, Inc. (OTC PINK:PACV) (the "Company"), a food and beverage holding company specializing in the distribution of consumer food, beverage and alcohol-related products, is pleased to announce

Key Financial Highlights for Q1 2020:

Revenues increased 520% to $6.7 million
Revenue growth driven by 80% increase from San Diego Farmers Outlet and the acquisition of Seaport Meat Company, which closed in December 2019
Gross profit increased 363% to $1.0 million

Management Commentary

Ms. Shannon Masjedi, Pacific Venture Group's Chief Executive Officer, commented, "I am extremely pleased with our start to 2020, as we continue to execute on our plans of integrating Seaport Meat Company and identifying efficiencies and growth opportunities. Our success is exemplified by our record quarterly revenue results of $6.7 million for the first quarter and the more recently announced record monthly revenue of $3.0 million for May."

Masjedi, continued, "Despite the much-publicized nationwide meat shortages due to meat processing facilities being shuttered because of the COVID-19 pandemic, Seaport Meat Company was successful in securing meat purchases to be able to supply existing and new customers. Our team has worked well in this unprecedented environment by identifying and pivoting to additional growth opportunities with new types of customers and increasing distribution points for each business, produce, dairy, meat and seafood."

Masjedi, concluded, "Our growth strategy for 2020 focuses on a three-prong approach that we believe will add value for our shareholders; (1) incrementally increase sales and profitability of San Diego Farmers Outlet and Seaport Meat Company, (2) expand Snöbar production and distribution and (3) acquire additional food production or distribution companies that are synergistic with San Diego Farmers Outlet and Seaport Meat Company. Additionally, our management team and Board have created a robust potential acquisition pipeline to complement our organic growth. We look forward to reporting our progress as it unfolds throughout 2020."

Financial Results for the Three Months Ended March 31, 2020:

Revenue for the three months ended March 31, 2020 was $6.7 million, an increase of $5.4 million, or 520%, as compared to $1.3 million for the three months ended March 31, 2019. The increase in revenue was driven by 80% organic growth at San Diego Farmers Outlet and the acquisition of Seaport Meat Company, which closed in December 2019. The Company had $1,318,715 inventory of saleable merchandise as of March 31, 2020 as compared to $198,475 for the period ending March 31, 2019.

Gross profit for the three months ended March 31, 2020 was $1.0 million, compared to $0.3 million for the three months ended March 31, 2019. The resulting gross margin was 15.1% for the three months ended March 31, 2020, compared to 21.6% for the three months ended March 31, 2019.

Selling, General and Administrative expenses for the three months ended March 31, 2020 were $973,820, an increase of $728,017, or 296%, compared to $245,803 for the three months ended March 31, 2019. The increase was primarily due to an increase in various expenses and business expansion.

Marketing and Advertising expenses for the three months ended March 31, 2020 were $14,718, an increase of $6,278, or 74%, compared to $8,440 for the three months ended March 31, 2019.

Professional Fees expenses for the three months ended March 31, 2020 were $190,257, an increase of $48,609, or 34%, compared to $141,648 for the three months ended March 31, 2019. The increase primarily related to accounting, legal fees and consulting services.

Depreciation and Amortization expenses for the three months ended March 31, 2020 were $161,892, compared to $6,476 for the three months ended March 31, 2019.

Total Operating expenses for the three months ended March 31, 2020 were $1,415,686, an increase of $1,013,320, or 252%, compared to $402,366 for the three months ended March 31, 2019. The increase primarily related to an increase in operating activities and an increase in salaries and wages due to the acquisition of Seaport Meat Company, which closed in December 2019.

Operating loss for the three months ended March 31, 2020 was $0.4 million, an increase of $0.3 million, or 226%, compared to $0.1 million for the three months ended March 31, 2019.

Total Non-Operating expenses for the three months ended March 31, 2020 were $390,000, an increase of $200,434, or 106%, compared to $189,566 for the three months ended March 31, 2019.

Net loss for the three months ended March 31, 2020 was $0.8 million, an increase of $0.5 million, or 160%, compared to $0.3 million for the three months ended March 31, 2019. The resulting loss per share for the three months ended March 31, 2020 was ($0.00) per diluted share, compared to ($0.00) per diluted share for the three months ended March 31, 2019.

About Pacific Ventures Group, Inc.

Pacific Ventures Group, Inc. (OTC PINK:PACV) is focused on expansion within the consumer products, food, beverage and alcohol-related industries. For more information on PACV, please visit www.pacvgroup.com. (You need to be at least 21 years of age (legal age to consume alcohol) to visit the section of the web site dedicated to SnöBar.)

Safe Harbor Statement

Forward-Looking Statement: This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include but are not limited to, the inability of the company to obtain financing sufficient to maintain its operations and execute its acquisition strategy; the inherent uncertainties associated with smaller reporting companies; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

Investors Contact:
ir@pacvgroup.com

ClearThink
nyc@clearthink.capital

SOURCE: Pacific Ventures Group, Inc.

ReleaseID: 594159

ROCHESTER, NY / ACCESSWIRE / June 17, 2020 / Document Security Systems, Inc. (NYSE American:DSS) a leader in anti-counterfeit, authentication and diversion protection technologies, today announced the pricing of an underwritten public offering of 769,230 shares of the Company's common stock at a price of $7.80 per share, with gross proceeds to the Company expected to be approximately $6 million before deducting underwriting discounts and commissions and other estimated offering expenses. The Company intends to use the net proceeds from this offering to fund development and growth of new business lines and acquisition opportunities, general corporate and working capital needs, and costs related to the closing of unprofitable business lines and facilities.

The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering to cover over-allotments, if any, at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about June 19, 2020, subject to customary closing conditions.

Aegis Capital Corp. is acting as sole bookrunner for the offering.

This offering is being made pursuant to an effective registration statement on Form S-1 (File No. 333-238587) previously filed with the U.S. Securities and Exchange Commission (the "SEC") and declared effective by the SEC on June 16, 2020. A final prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov.

Electronic copies of the final prospectus, when available, may be obtained by contacting Aegis Capital Corp., Attention: Syndicate Department, 810 7th Avenue, 18th floor, New York, NY 10019, by email at syndicate@aegiscap.com, or by telephone at (212) 813-1010. Before investing in this offering, interested parties should read in their entirety the prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus, which provide more information about the Company and such offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Document Security Systems, Inc.

DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPO's. Its historic business revolves around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a highly successful global business veteran of more than 40 years specializing in corporate transformation while managing risk. He has successfully restructured more than 35 corporations with a combined value of $25 billion.

For more information on DSS visit http://www.dsssecure.com.

Investor Contact:

Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
Dave@redchip.com

Safe Harbor Disclosure

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements related to the Company's ability to complete the financing, its intended use of proceeds and other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results or events to differ materially from those projected. These risks and uncertainties, many of which are beyond our control, include: the risk that the public offering of common stock may not close; risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of development activities; our ability to attract, integrate and retain key personnel; our need for substantial additional funds; patent and intellectual property matters; competition; as well as other risks described in the section entitled "Risk Factors" in the prospectus and in our other filings with the SEC, including, without limitation, our reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

SOURCE: Document Security Systems

ReleaseID: 594190

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC / ACCESSWIRE / June 17, 2020 / Barksdale Resource Corp. ("Barksdale" or the "Company") (TSXV:BRO)(OTCQB:BRKCF) is pleased to announce that it has secured an option to acquire a 100% interest in a patented mining claim. The property is located within close proximity to the Company's projects in Arizona and is surrounded by South32's Hermosa project.

Under the terms of an option agreement dated June 15, which is subject to TSX Venture Exchange acceptance, Barksdale will pay the arm's length vendors ("Optionors") 89,445 common shares of Barksdale to acquire a twelve-month option over the property. The option will give Barksdale the right, but not the obligation, to acquire a 100% interest in the patented mineral claim from the Optionors in consideration for US$50,000 worth of Barksdale shares and US$50,000 in cash. All shares issued to the Optionors will be subject to a four month hold period.

Barksdale's President and CEO, Rick Trotman commented, "This marks the fifth property deal that Barksdale has inked since late 2017 when we made our commitment to this world-class mineral district. Over the past few months, we have seen an increase in the number of local owners interested in working with us and are hopeful that we will be able to continue to further consolidate our land position within the district."

About Barksdale Resources Corp.

Barksdale is a base metal exploration company headquartered in Vancouver, BC, that is focused on the acquisition and exploration of highly prospective base metal projects in the United States. Barksdale's portfolio of assets is located within a world-class base metal district in southern Arizona and is surrounded by some of the world's largest mining companies.

ON BEHALF OF BARKSDALE RESOURCES CORP.

Rick Trotman
President and Chief Executive Officer
720-447-7705
Rick@barksdaleresources.com

Terri Anne Welyki
Vice President of Communications
778-238-2333
TerriAnne@barksdaleresources.com

For more information please phone 778-238-2333, email info@barksdaleresources.com or visit www.BarksdaleResources.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

This new release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to or for the account or benefit of a U.S. person (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking information" under applicable Canadian securities legislation. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Barksdale Resource Corp.

ReleaseID: 594146

OTTAWA, ON / ACCESSWIRE / June 17, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, today provides an update on the development of its ARDS-003 intravenous drug product for the potential treatment of cytokine release syndrome (CRS) and the potential prevention of Acute Respiratory Distress Syndrome (ARDS) development in hospitalized patients with COVID-19.

Earlier this month, the corporation submitted a meeting request to the FDA, along with an information package as part of the COVID-19 Public Health Emergency: General Considerations for Pre-IND Meeting Requests for COVID-19 Related Drugs and Biological Products. This PIND package contains Tetra's proposed plan to investigate ARDS-003 in patients infected with COVID-19 and its registration strategy to bring this new drug into the market, should safety and efficacy be demonstrated. We will provide an update to the market as soon as we receive feedback from the FDA. Similarly, the corporation is also seeking guidance from Health Canada for its ARDS-003 proposed drug development program in the same patient population.

Tetra is preparing the regulatory file to initiate the filing of clinical trial applications in Canada and the USA. The corporation initiated several toxicology studies earlier this month. This includes microsome and hepatocyte stability studies, protein binding assays, intravenous compatibility, hERG assay for cardiovascular safety, single dose intravenous pharmacokinetic studies in rats and dogs, and reverse mutation and in vitro micronucleus assays for genotoxicity. During the next month, additional toxicology studies will be initiated in parallel as Tetra prepares the safety data package to support the administration of this experimental drug to patients with COVID-19.

In parallel to the toxicology program, the development, improvement, and optimization of the Active Pharmaceutical Ingredient (API) and finished product manufacturing processes as well as GMP compliance are moving to ensure readiness for a fast initiation of clinical studies.

Dr. Guy Chamberland, CEO & CRO of Tetra commented, "The Company is not making any express or implied claims that its product has the ability to eliminate, cure and/or contain the COVID-19 virus at this time. The nonclinical safety program is moving forward as planned by the drug development team. We have designed the nonclinical safety program to be able to initiate studies in both healthy volunteers and patients. This type of strategy provides Tetra with the most flexibility to rapidly initiate clinical trials as opportunities occur."

About Tetra Bio-Pharma

Tetra Bio-Pharma (TSXV:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed and approved, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research and development strategies, including the success of this product or any other product, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact Tetra Bio-Pharma Inc.:

Investor Contact:

Alpha Bronze, LLC
Mr. Pascal Nigen
Phone: + 1 (646) 255-0433
tetra@alphabronze.net

Media Contact:

energi PR
Ms. Carol Levine APR, FCPRS
Phone: + 1 (416) 425-9143 ext. 226
Mobile: + 1 (514) 703-0256
carol.levine@energipr.com

SOURCE: Tetra Bio-Pharma

ReleaseID: 594147

VANCOUVER, BC / ACCESSWIRE / June 17, 2020 / Skeena Resources Limited (TSXV:SKE)(OTCQX:SKREF) ("Skeena" or the "Company") is pleased to update its exploration and development plans for the Eskay Creek gold-silver project ("Eskay Creek" or the "Project") located in the Golden Triangle of northwest British Columbia.

Surface-based drilling at Eskay Creek is on schedule to begin in late June 2020 with two surface drill rigs. Incorporating the newly developed workflows associated with the Company's vigorous Infection Prevention Strategy (see news release dated June 4, 2020), additional drill rigs will ultimately be added to the program utilizing a staged approach. The drilling schedule will culminate with eight to ten drill rigs performing delineation and exploratory drilling across the project until December 2020.

Initially, drilling will focus on the completion of the Phase I program of infill on the 21A, 21B and 21C Zones (24,000 metres) paralleled by resource expansion drilling in the near-mine environment. The Company is permitting 137,000 metres of exploratory drilling to test both brownfield and greenfield targets.

Skeena has also engaged Dias Geophysical to perform a high-resolution, regional Induced Polarization (IP) survey and a detailed airborne gradiometer magnetics survey at Eskay Creek. These geophysical programs are expected to occur in July and August 2020.

Walter Coles, Skeena's President and CEO commented that, "Skeena has spent almost $25 million at Eskay Creek since we optioned the project from Barrick. Due to the exercise of warrants expiring last week, Skeena's cash position is approaching $50 million. The company is fully funded for an exploration budget that will total approximately $45 million for the balance of the year as we look to aggressively advance Eskay Creek."

About Skeena

Skeena Resources Limited is a junior Canadian mining exploration company focused on developing prospective precious metal properties in the Golden Triangle of northwest British Columbia, Canada. The Company's primary activities are the exploration and development of the past-producing Eskay Creek gold-silver mine. The Company released a robust Preliminary Economic Assessment in late 2019 and is currently focused on infill and exploration drilling at Eskay Creek to advance the project to Pre-feasibility. Skeena is also exploring the past-producing Snip gold mine.

On behalf of the Board of Directors of Skeena Resources Limited,

Walter Coles Jr.
President & CEO

Qualified Persons

Exploration activities at the Eskay Creek Project are administered on site by the Company's Exploration Managers, Colin Russell, P.Geo. and Adrian Newton, P.Geo. In accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects, Paul Geddes, P.Geo. Vice President Exploration and Resource Development, is the Qualified Person for the Company and has prepared, validated and approved the technical and scientific content of this news release. The Company strictly adheres to CIM Best Practices Guidelines in conducting, documenting, and reporting its exploration activities on its projects.

Cautionary note regarding forward-looking statements

Certain statements made and information contained herein may constitute "forward looking information" and "forward looking statements" within the meaning of applicable Canadian and United States securities legislation. These statements and information are based on facts currently available to the Company and there is no assurance that actual results will meet management's expectations. Forward-looking statements and information may be identified by such terms as "anticipates", "believes", "targets", "estimates", "plans", "expects", "may", "will", "could" or "would". Forward-looking statements and information contained herein are based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and reserves, the realization of resource and reserve estimates, metal prices, taxation, the estimation, timing and amount of future exploration and development, capital and operating costs, the availability of financing, the receipt of regulatory approvals, environmental risks, title disputes and other matters. While the Company considers its assumptions to be reasonable as of the date hereof, forward-looking statements and information are not guarantees of future performance and readers should not place undue importance on such statements as actual events and results may differ materially from those described herein. The Company does not undertake to update any forward-looking statements or information except as may be required by applicable securities laws.

Neither TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

CONTACT:

Walt Coles Jr.,
President & CEO
Kelly Earle, Vice President Communications
Email: kearle@skeenaresources.com
Tel: (604) 684-8725

SOURCE: Skeena Resources Limited

ReleaseID: 594127